On November 27, 2024, Christian Voigtlander, Chief Operating Officer of ICU Medical Inc, sold 1,430 shares of the company, as reported in a SEC Filing. Following this transaction, the insider now owns 0 shares of the company.
ICU Medical Inc (ICUI, Financial) is a company that develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications. The company is known for its innovative products that help improve patient care and safety.
The insider transaction history for ICU Medical Inc shows that there have been 0 insider buys in total over the past year. Meanwhile, there have been 22 insider sells over the same timeframe.
Over the past year, Christian Voigtlander has sold a total of 37,253 shares and purchased 0 shares.
Shares of ICU Medical Inc were trading for $158 apiece on the day of Christian Voigtlander’s recent sale. This gives the stock a market cap of $3.911 billion.
With a price of $158 and a GuruFocus Value of $174.84, ICU Medical Inc has a price-to-GF-Value ratio of 0.9. This means the stock is fairly valued based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus that is calculated based on the following three factors:
- Historical multiples (price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow) that the stock has traded at.
- A GuruFocus adjustment factor based on the company’s past returns and growth.
- Future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
